https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-sponsored-research-agreement-with-md-anderson-for-potential-cancer-treatment-technologies-301066566.html
0
0
5/28/20 at 12:00pm
Organization
PRNewswire
50 words
0
Comments
HOUSTON, May 28, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system…
You are the first to view
Create an account
or login to join the discussion